Counting MSCs for cell therapeutic applications

Webinar with Boston BioLife

Counting primary mesenchymal stem cells is challenging as many counting techniques fail to discriminate between cells and artifacts or will give high variations between different users. In this webinar with Boston BioLife counting MSCs for cell therapeutic applications, learn how to determine viability and total cell count of mesenchymal stem cells derived from lipoaspirates and bone marrow aspirates using NucleoCounter® instruments.

Presenter: Tanja Seeger, PhD / Field Application Scientist 
Hosted by Boston Biolife


We welcome and encourage blog users to leave comments. ChemoMetec reserves the right to moderate all comments and delete any that could be determined as i) irrelevant, ii) containing spam, iii) containing profanity, iv) deemed offensive or v) containing questionable content. We reserve the right to withhold any comment from being published. ChemoMetec is not responsible for the content in comments, which represent solely the views of the commenter.


Leave a comment

Your email address will not be published. Required fields are marked *